You are here:

calcium carbonate + cholecalciferol (Kalcipos-D®)

Advice

following an abbreviated submission:

calcium carbonate and cholecalciferol (Kalcipos-D®) is accepted for use within NHS Scotland.

Indications under review:

  • Prevention and treatment of calcium and vitamin D deficiency in the elderly.
  • Vitamin D and calcium supplement in addition to specific osteoporosis treatment of patients who are at risk of vitamin D and calcium deficiency.


This is a new combination product with a different ratio of calcium to cholecalciferol than alternative combination preparations. It is a similar price to an alternative product containing 800IU of cholecalciferol per tablet but is more expensive than some other calcium and cholecalciferol combinations. Any overall budget impact is likely to be small.

Drug Details

Drug Name: calcium carbonate + cholecalciferol (Kalcipos-D®)
SMC Drug ID: 718/11
Manufacturer: Meda Pharmaceuticals Ltd
Indication: Prevention and treatment of calcium and vitamin D deficiency in the elderly
BNF Category:
Sub Category: 9.6 Vitamins
Submission Type: Abbreviated Submission
Status: Accepted
Date Advice Published: 8 August 2011

Back